FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2568999452> ?p ?o ?g. }

• W2568999452 endingPage "e5803" @default.
• W2568999452 startingPage "e5803" @default.
• W2568999452 abstract "Background: Previous studies indicated that the puerarin injection has been widely employed in China for the treatment of acute ischemic stroke. We aim to evaluate the efficacy and safety of the puerarin injection for the treatment of acute ischemic stroke. Methods: A systematic literature search was performed in PUBMED, EMBASE, SPRINGER LINK, Scopus, Cochrane Library, China National Knowledge Infrastructure (CNKI), VIP Journals Database, Wanfang database and the China Biological Medicine database before November 2016, randomized controlled clinical trials (RCTs) of puerarin injection treating acute ischemic stroke were included. In addition, we searched reference lists of relevant retrieved articles. Two authors extracted data independently. The effective rate, the neurologic deficit score, the blood rheology indexes, and fibrinogen were assessed and analyzed by the Review Manager 5.3 software. The continuous variables were expressed as MD with 95% CI and dichotomous data used RR or ORs. Adverse reactions related to the puerarin injection were also examined. Results: Thirty-five RCTs with a total of 3224 participants were identified in the meta-analysis. The combined results of 32 trials indicated that the puerarin injection was better than control drugs at the clinical effective rate (RR 1.22, 95% CI 1.17 to 1.28, P < 0.001) and 16 studies showed the neurological deficit was significantly improved (MD –3.69, 95% CI –4.67 to –2.71, P < 0.001); the hemorheology index and fibrinogen were much lower with the puerarin injection when compared with western conventional medicines (WCM) or other control drugs (the whole blood viscosity: MD –0.89, 95% CI –1.37 to –0.41, P < 0.001; the HCT: MD –0.04, 95% CI –0.06 to –0.02, P < 0.001; the fibrinogen: MD –0.64, 95% CI –0.96 to –0.31, P < 0.001). Eleven trials reported that the adverse reactions related to the puerarin injection included facial flushing, dizziness, vomiting, nausea, and other mild gastrointestinal discomfort and allergic reaction. No serious adverse drug reactions were reported. Conclusions: Puerarin injection may be more effective and relatively safe in clinic for treating acute ischemic stroke. However, the current evidence is insufficient due to the poor methodological quality and lack of adequate safety data. Further RCTs are required to examine its efficacy." @default.
• W2568999452 created "2017-01-13" @default.
• W2568999452 creator A5002235227 @default.
• W2568999452 creator A5003813906 @default.
• W2568999452 creator A5010775196 @default.
• W2568999452 creator A5017603170 @default.
• W2568999452 creator A5033350250 @default.
• W2568999452 creator A5034062124 @default.
• W2568999452 creator A5040180700 @default.
• W2568999452 creator A5043856133 @default.
• W2568999452 creator A5058366139 @default.
• W2568999452 date "2017-01-01" @default.
• W2568999452 modified "2023-09-27" @default.
• W2568999452 title "Efficacy and safety of puerarin injection in curing acute ischemic stroke" @default.
• W2568999452 cites W1558352361 @default.
• W2568999452 cites W1966146014 @default.
• W2568999452 cites W1975153455 @default.
• W2568999452 cites W1979212937 @default.
• W2568999452 cites W2021199020 @default.
• W2568999452 cites W2037233673 @default.
• W2568999452 cites W2063528788 @default.
• W2568999452 cites W2071941255 @default.
• W2568999452 cites W2085077339 @default.
• W2568999452 cites W2106576386 @default.
• W2568999452 cites W2108238225 @default.
• W2568999452 cites W2130106288 @default.
• W2568999452 cites W2134012154 @default.
• W2568999452 cites W2134404494 @default.
• W2568999452 cites W2169079203 @default.
• W2568999452 cites W2491630233 @default.
• W2568999452 doi "https://doi.org/10.1097/md.0000000000005803" @default.
• W2568999452 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5228693" @default.
• W2568999452 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28072733" @default.
• W2568999452 hasPublicationYear "2017" @default.
• W2568999452 type Work @default.
• W2568999452 sameAs 2568999452 @default.
• W2568999452 citedByCount "31" @default.
• W2568999452 countsByYear W25689994522017 @default.
• W2568999452 countsByYear W25689994522018 @default.
• W2568999452 countsByYear W25689994522019 @default.
• W2568999452 countsByYear W25689994522020 @default.
• W2568999452 countsByYear W25689994522021 @default.
• W2568999452 countsByYear W25689994522022 @default.
• W2568999452 countsByYear W25689994522023 @default.
• W2568999452 crossrefType "journal-article" @default.
• W2568999452 hasAuthorship W2568999452A5002235227 @default.
• W2568999452 hasAuthorship W2568999452A5003813906 @default.
• W2568999452 hasAuthorship W2568999452A5010775196 @default.
• W2568999452 hasAuthorship W2568999452A5017603170 @default.
• W2568999452 hasAuthorship W2568999452A5033350250 @default.
• W2568999452 hasAuthorship W2568999452A5034062124 @default.
• W2568999452 hasAuthorship W2568999452A5040180700 @default.
• W2568999452 hasAuthorship W2568999452A5043856133 @default.
• W2568999452 hasAuthorship W2568999452A5058366139 @default.
• W2568999452 hasBestOaLocation W25689994521 @default.
• W2568999452 hasConcept C126322002 @default.
• W2568999452 hasConcept C127413603 @default.
• W2568999452 hasConcept C142724271 @default.
• W2568999452 hasConcept C168563851 @default.
• W2568999452 hasConcept C197934379 @default.
• W2568999452 hasConcept C204787440 @default.
• W2568999452 hasConcept C2776478404 @default.
• W2568999452 hasConcept C2778356392 @default.
• W2568999452 hasConcept C2780645631 @default.
• W2568999452 hasConcept C2994203641 @default.
• W2568999452 hasConcept C71924100 @default.
• W2568999452 hasConcept C78519656 @default.
• W2568999452 hasConcept C78520924 @default.
• W2568999452 hasConcept C95190672 @default.
• W2568999452 hasConceptScore W2568999452C126322002 @default.
• W2568999452 hasConceptScore W2568999452C127413603 @default.
• W2568999452 hasConceptScore W2568999452C142724271 @default.
• W2568999452 hasConceptScore W2568999452C168563851 @default.
• W2568999452 hasConceptScore W2568999452C197934379 @default.
• W2568999452 hasConceptScore W2568999452C204787440 @default.
• W2568999452 hasConceptScore W2568999452C2776478404 @default.
• W2568999452 hasConceptScore W2568999452C2778356392 @default.
• W2568999452 hasConceptScore W2568999452C2780645631 @default.
• W2568999452 hasConceptScore W2568999452C2994203641 @default.
• W2568999452 hasConceptScore W2568999452C71924100 @default.
• W2568999452 hasConceptScore W2568999452C78519656 @default.
• W2568999452 hasConceptScore W2568999452C78520924 @default.
• W2568999452 hasConceptScore W2568999452C95190672 @default.
• W2568999452 hasIssue "1" @default.
• W2568999452 hasLocation W25689994521 @default.
• W2568999452 hasLocation W25689994522 @default.
• W2568999452 hasLocation W25689994523 @default.
• W2568999452 hasOpenAccess W2568999452 @default.
• W2568999452 hasPrimaryLocation W25689994521 @default.
• W2568999452 hasRelatedWork W2350859835 @default.
• W2568999452 hasRelatedWork W2368615813 @default.
• W2568999452 hasRelatedWork W2375970370 @default.
• W2568999452 hasRelatedWork W2381982637 @default.
• W2568999452 hasRelatedWork W2464549863 @default.
• W2568999452 hasRelatedWork W2568999452 @default.
• W2568999452 hasRelatedWork W2802322663 @default.
• W2568999452 hasRelatedWork W2914141471 @default.
• W2568999452 hasRelatedWork W3029323012 @default.

• next